FDA Expands Use of Molecularly Targeted Therapeutic for Lung Cancer
The U.S. Food and Drug Administration (FDA) recently approved the use of molecularly targeted therapeutic afatinib (Gilotrif) for treating...
Category: Research
The U.S. Food and Drug Administration (FDA) recently approved the use of molecularly targeted therapeutic afatinib (Gilotrif) for treating...
On April 19, Sven Bilke, PhD, staff scientist in the Genetics Branch of the National Cancer Institute, discussed his...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the antiangiogenic...
In a study presented at the AACR Annual Meeting 2016 on April 19, researchers engineered an organic bispecific adaptor...
Earlier this month, the U.S. Food and Drug Administration (FDA) approved a new colorectal cancer screening test, the ‘System,...
Data presented at the AACR Annual Meeting 2016, on April 19, showed that a microdevice about the size of...
Immunotherapy was one of the hottest topics at last year’s AACR Annual Meeting, and this year the trend is...
Last week, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for hematologist-oncologists when it...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention found an association between glycemic index (a...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of crizotinib (Xalkori)...